Publications


Progression-dependent transport heterogeneity of breast cancer liver metastases as a factor in therapeutic resistance;
Ziemys, A, Yokoi, K, Kai, M, Liu, YT, Kojic, M, Simic, V, Milosevic, M, Holder, AM & Ferrari, M 2018, Journal of Controlled Release, vol. 291, pp. 99-105. DOI: 10.1016/j.jconrel.2018.10.014

Unexpected behaviors in molecular transport through size-controlled nanochannels down to the ultra-nanoscale;
Bruno, G, Di Trani, N, Hood, RL, Zabre, E, Filgueira, CS, Canavese, G, Jain, P, Smith, Z, Demarchi, D, Hosali, S, Pimpinelli, A, Ferrari, M & Grattoni, A 2018, Nature communications, vol. 9, no. 1, 1682. DOI: 10.1038/s41467-018-04133-8

Nanofluidic microsystem for sustained intraocular delivery of therapeutics;
Di Trani, N, Jain, P, Chua, CYX, Ho, JS, Bruno, G, Susnjar, A, Pons-Faudoa, FP, Sizovs, A, Lyle Hood, R, Smith, ZW, Ballerini, A, Filgueira, CS & Grattoni, A 2018, Nanomedicine: Nanotechnology, Biology, and Medicine. DOI: 10.1016/j.nano.2018.11.002

Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy for cancer treatment;
Chua, CYX, Filgueira, CS & Grattoni, A 2018, SITC 33rd Annual Meeting, Washington DC, United States, 11/9/18 - 11/11/18, .

METHOD AND APPARATUS FOR THE FAIL-SAFE TERMINATION OF IN VIVO DRUG DELIVERY FROM AN IMPLANTABLE DRUG DELIVERY SYSTEM;
Farina, M, Hood, RL & Grattoni, A 2018, , Patent No. US2018280617, IPC No. A61M 5/ 142 A I.

Cancer in adolescence - the girlfriend's story;
Veneroni, L, Silva, M, Signoroni, S, Gaggiotti, P, Clerici, CA, Proserpio, T, Massimino, M & Ferrari, A 2018, Tumori, vol. 104, no. 5. DOI: 10.5301/tj.5000686

Chemotherapy sensitizes therapy-resistant cells to mild hyperthermia by suppressing heat shock protein 27 expression in triple-negative breast cancer;
Mu, C, Wu, X, Zhou, X, Wolfram, J, Shen, J, Zhang, D, Mai, J, Xia, X, Holder, AM, Ferrari, M, Liu, X & Shen, H 2018, Clinical Cancer Research, vol. 24, no. 19, pp. 4900-4912. DOI: 10.1158/1078-0432.CCR-17-3872

Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis;
Chua, CYX, Jain, P, Ballerini, A, Bruno, G, Hood, RL, Gupte, M, Gao, S, Di Trani, N, Susnjar, A, Shelton, K, Bushman, LR, Folci, M, Filgueira, CS, Marzinke, MA, Anderson, PL, Hu, M, Nehete, P, Arduino, RC, Sastry, JK & Grattoni, A 2018, Journal of Controlled Release, vol. 286, pp. 315-325. DOI: 10.1016/j.jconrel.2018.08.010

Intratumoral Immunotherapy Delivery Via Minimally Invasive Nanochannel Implant;
Susnjar, A, Chua, CYX, Rhudy, JR, Ho, J, Jain, P, Singh, S, Yee, C, Filgueira, CS, Butler, EB & Grattoni, A 2018, 2018 AIChE Annual Meeting, 3rd Bioengineering & Translational Medicine Conference, Boston, United States, 9/27/18 - 9/28/18, .

Intratumoral Immunotherapy Delivery via Minimally Invasive Nanochannel Implant;
Grattoni, A & Susnjar, A 2018, 3rd Bioengineering and Translational Medicine Conference , Boston, United States, 9/27/18 - 9/27/18, .